Featured Research

from universities, journals, and other organizations

Standard IVF medication dose less effective in obese women

Date:
March 20, 2014
Source:
Endocrine Society
Summary:
Obese women may need a different dose of medication than normal weight women in order to successfully have their eggs harvested for in vitro fertilization (IVF), according to a new study. IVF is a type of assisted reproductive technology used to help women become pregnant. More than 1 percent of all infants born in the United States each year are conceived using assisted reproductive technology.

Obese women may need a different dose of medication than normal weight women in order to successfully have their eggs harvested for in vitro fertilization (IVF), according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Related Articles


IVF is a type of assisted reproductive technology used to help women become pregnant. More than 1 percent of all infants born in the United States each year are conceived using assisted reproductive technology, according to the U.S. Centers for Disease Control and Prevention.

IVF involves mixing sperm with an egg outside the body and then transferring the resulting embryo into the uterus. The goal is to harvest many eggs to ensure a successful IVF cycle. As part of the egg harvesting process, women receive a medication called a GnRH antagonist to prevent the brain from giving the ovulation signal too early and ruining the egg harvest.

"If the GnRH antagonist clears from a woman's body too quickly, there is a risk that the brain will signal the body to discharge the eggs from the ovaries too early," said one of the study's authors, Nanette Santoro, MD, of the University of Colorado at Denver. "We were surprised to find obese women were more likely to experience this, and it may be one reason why overweight and obese women have a higher rate of unsuccessful IVF cycles than normal weight women do."

The interventional study examined the rate of medication absorption in 10 obese and 10 normal-weight women. Researchers gave each participant a dose of a GnRH antagonist used in IVF procedures. To determine how quickly the medication was absorbed, the participants had their blood frequently sampled for six hours, beginning eight hours after the medication was first administered.

The study found the GnRH antagonist cleared out of the obese women's systems more quickly than the normal-weight women. In addition, half of the obese women had a rebound of luteinizing hormone -- the hormone that causes the body to release eggs -- during the 14-hour monitoring period.

"Our findings indicate obese women may need a different or increased dosing regimen to improve fertility treatment outcomes," Santoro said. "Given the cost of IVF and stress of infertility, it is important to maximize each woman's chances of conceiving a child."


Story Source:

The above story is based on materials provided by Endocrine Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lauren W. Roth, Erica L. Bradshaw-Pierce, Amanda A. Allshouse, Jennifer Lesh, Justin Chosich, Andrew P. Bradford, Alex J. Polotsky, Nanette Santoro. Evidence of GnRH Antagonist Escape in Obese Women. The Journal of Clinical Endocrinology & Metabolism, 2014; jc.2013-3598 DOI: 10.1210/jc.2013-3598

Cite This Page:

Endocrine Society. "Standard IVF medication dose less effective in obese women." ScienceDaily. ScienceDaily, 20 March 2014. <www.sciencedaily.com/releases/2014/03/140320134720.htm>.
Endocrine Society. (2014, March 20). Standard IVF medication dose less effective in obese women. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2014/03/140320134720.htm
Endocrine Society. "Standard IVF medication dose less effective in obese women." ScienceDaily. www.sciencedaily.com/releases/2014/03/140320134720.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins